Welcome to Medications.com

UPDATE 1-Shire 2007 earnings top forecast, upbeat on Vyvanse - Reuters

Revenues rose 36 percent to $2.44 billion, boosted by a 19 percent rise in sales of Adderall XR, Shire's current top-selling ADHD treatment, ...

http://www.reuters.com/article/ma... | Posted: Thu Feb 21 07:18:54 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea